Provided by Tiger Trade Technology Pte. Ltd.

OptimizeRx Corporation

7.71
-0.2500-3.14%
Post-market: 7.710.00000.00%19:42 EDT
Volume:131.48K
Turnover:1.02M
Market Cap:144.64M
PE:31.33
High:8.22
Open:8.21
Low:7.59
Close:7.96
52wk High:22.25
52wk Low:4.54
Shares:18.76M
Float Shares:14.50M
Volume Ratio:0.57
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2461
EPS(LYR):0.2700
ROE:3.68%
ROA:4.22%
PB:1.10
PE(LYR):28.56

Loading ...

Lake Street Sticks to Its Buy Rating for OptimizeRx (OPRX)

TIPRANKS
·
May 11

BRIEF-Optimizerx Launches Programmatic Access To Authenticated EHR Advertising At Scale

Reuters
·
May 11

OptimizeRx Launches Programmatic Access to Authenticated Ehr Advertising at Scale

THOMSON REUTERS
·
May 11

OptimizeRx Corp expected to post breakeven results a share - Earnings Preview

Reuters
·
May 09

OptimizeRx announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 30

OptimizeRx announces availability of 2026 ESG report

Reuters
·
Apr 30

OptimizeRx sets first-quarter results conference call for May 12

Reuters
·
Apr 28

OptimizeRx files Form 3 for director Presti Mariyamma Varghese

Reuters
·
Apr 22

Myomo appoints Will Febbo to board of directors

Reuters
·
Apr 17

OptimizeRx names Microsoft Health & Life Sciences COO Mary Varghese Presti to board

Reuters
·
Apr 09

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX) and Curis (CRIS)

TIPRANKS
·
Apr 09

OptimizeRx replaces auditor UHY with Grant Thornton after internal control weakness disclosure

Reuters
·
Mar 31

OptimizeRx publishes corporate presentation on its Dynamic Audience Activation Platform and FY2026 guidance of USD 109-114 million revenue

Reuters
·
Mar 18

OptimizeRx Price Target Cut to $11.00/Share From $28.00 by B. Riley Securities

Dow Jones
·
Mar 07

OptimizeRx Is Maintained at Equal-Weight by Stephens & Co.

Dow Jones
·
Mar 07

OptimizeRx trading halted, volatility trading pause

TIPRANKS
·
Mar 06

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM

Reuters
·
Mar 06

B. Riley Adjusts OptimizeRx Price Target to $11 From $28, Maintains Buy Rating

MT Newswires Live
·
Mar 06

OptimizeRx price target lowered to $18 from $32 at Roth Capital

TIPRANKS
·
Mar 06

BRIEF-Optimizerx Corp Enters Amendment No. 4 To Financing Agreement- SEC Filing

Reuters
·
Mar 06